MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04958cam a2200589 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn952772313 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221128211659.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
110322s2011 nyua ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2019714320 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
|---|
| Record control number |
015875048 |
| Source |
Uk |
| 019 ## - |
|---|
| -- |
779844104 |
| -- |
1066598908 |
| -- |
1081262926 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9781620810453 |
| Qualifying information |
ebook |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
162081045X |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
1613244444 |
| Qualifying information |
hardcover : alk. paper |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781613244449 |
| Qualifying information |
hardcover : alk. paper |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
439182 |
| -- |
(N$T) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)952772313 |
| Canceled/invalid control number |
(OCoLC)779844104 |
| -- |
(OCoLC)1066598908 |
| -- |
(OCoLC)1081262926 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QW 805 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
071000 |
| Source |
bisacsh |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
DNA vaccines : |
| Subtitle |
types, advantages, and limitations |
| Statement of responsibility, etc |
|
| Medium |
[E-Book] |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Nova Biomedical Books, |
| Date of production, publication, distribution, manufacture, or copyright notice |
c2011. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES TITLE |
|---|
| Series statement |
Immunology and immune system disorders |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - CONTENTS |
|---|
| Contents |
DNA VACCINES: TYPES, ADVANTAGES AND LIMITATIONS ; IMMUNOLOGY AND IMMUNE SYSTEM DISORDERS ; DNA VACCINES: TYPES, ADVANTAGES AND LIMITATIONS ; Contents ; Preface ; Novel Carrier Adjuvant for DNA Vaccination ; Abstract ; 1. Introduction ; 2. Immunology of DNA Vaccines: Mode of Action and Immune Response Induction ; 3. Barriers in DNA Vaccine Delivery and Possible Modes to Overcome these Barriers ; 4. Novel Strategies for DNA Delivery ; 4.1. Lipid Based Carrier Adjuvants for DNA Vaccination ; 4.1.1. Liposomes ; 4.1.2. Virosomes. |
| 505 8# - CONTENTS |
|---|
| Contents |
4.2. Polymers and Polymeric Carriers Systems 4.2.1. Polyethylenimine ; 4.2.2. Polylysine ; 4.2.3. Chitosan ; 4.2.4. Dendrimers ; 5. Concluding Remark and Future Prospects ; References ; Improving the Immunogenicity of DNA Vaccines: A Nano-Sized Task? ; Abstract ; Introduction ; Improving Immunogenicity of Plasmid DNA Vaccines ; Routes of Delivery of Plasmid DNA Vaccines ; Physical Delivery Systems of Plasmid DNA Vaccines ; Needle-Free Delivery Methods ; Expression Optimization ; Cytokines ; Delivery Vectors for DNA Vaccines ; Bacterial Vectors ; Viral Vectors. |
| 505 8# - CONTENTS |
|---|
| Contents |
DNA and RNA Replicons Nano-Sized Vehicles for Gene Delivery ; Inorganic to Biomaterial -- Past to Future ; Size Determines the Fate of Particles ; Conclusion ; References ; Novel Delivery Strategies for DNA ; Abstract ; I. Introduction ; II. Optimization of Immunogenicity of DNA Vaccines ; 2.1. Choice of Targets and Expression Plasmid for DNA Vaccines ; 2.2. Selection of High Expression Plasmids for DNA Vaccines ; 2.3. Codon Optimization for Higher Gene Expression ; 2.4. Adjuvant Choice for DNA Vaccines ; III. DNA Delivery Strategies ; 3.1. Invasive Delivery. |
| 505 8# - CONTENTS |
|---|
| Contents |
3.1.1. Needle Injection 3.1.2. In Vivo Electroporation ; 3.1.3. Tattoo Gun Delivery ; 3.2. Non-Invasive Topical Delivery Method ; 3.2.1. Tape Stripping ; 3.2.2. Nanopatch Delivery ; 3.2.3. Nano-Particle Mediated Delivery ; 3.3. Viral-Mediated DNA Delivery Systems ; 3.4. Non-Viral Gene Delivery Systems ; 3.5. Novel Delivery Methods ; 3.5.1. Laser Mediated Delivery ; 3.5.2. Ultrasound Mediated Delivery System ; III. Future Directions ; References ; Recent Advances in DNA Vaccines ; Abstract ; Introduction ; DNA Vaccines X Traditional Vaccine Approaches ; Components of a DNA Vaccine. |
| 505 8# - CONTENTS |
|---|
| Contents |
How DNA Vaccines Work Delivery Methods ; Advantages X Limitations ; Strategies to Enhance Immunogenicity of DNA Vaccines ; Modifications of Plasmid Basic Design ; Delivery Methods ; Target to Dendritic Cells ; Improved Immunization Protocols ; Adjuvants ; Conclusion ; References ; Co-Administration of Gamma Interferon Gene with DNA Vaccine Expressing Duck Hepatitis B Virus (DHBV) Proteins Enhances Therapeutic Efficacy of DNA-Based Immunization in Chronic Virus Carriers ; Abstract ; Introduction ; Materials and Methods ; Animals ; DNA Immunization. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Master record variable field(s) change: 072 - OCLC control number change |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
DNA vaccines. |
| 650 #2 - SUBJECT HEADINGS |
|---|
| Subject term |
Vaccines, DNA. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Donnelly, Erin C. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Dixon, Arthur M. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Immunology and immune system disorders. |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=439182">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=439182</a> |
| Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record. |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL3021072 |
| 938 ## - |
|---|
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10681272 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
439182 |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
7561576 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
N$T |